From the CEO

Highlights: • Commercial agreement with Health Metrics, a market leader in providing software solutions to the Health and Aged Care markets in Australia and New Zealand. • Provides easy access to PainChek and the benefits of full integration for those Aged Care Facilities using Health Metrics eCase management software system. • PainChek and Health Metrics will also collaborate to market the PainChek App to customers of Health Metrics in Australia. The PainChek™ App improves a patient's quality of life by providing to caregivers real-time, point of care diagnostic information, utilising artificial intelligence and facial recognition technology, to detect facial expressions and modalities that indicate the presence of pain.  DOWNLOAD PDF...

27 March, 2018

The Android version of the PainChek™ mobile application has been completed and is undergoing beta testing prior to general release. The PainChek™ App Android version incorporates all of the technology and functionality that is already available in the iOS (Apple) version and is projected to be available for commercial release in the Enterprise market in Q1 2018 and be available for the consumer market from Q2 2018 onwards. Designed to run on Android versions 6.0 and later, the App is initially being validated on the Samsung S6, S7 and S8 smartphone line. It is anticipated that any mid- to high-end smart phone or tablet released from 2015 onwards to be able to run the PainChek™ Android application. Future enhancements to the IOS and the Android versions of PainChek will occur in parallel, to ensure all users have access to the latest features....

30 January, 2018

Highlights: • Second study confirms excellent clinical performance of PainChek™ • 400 paired assessments in 34 residents showed PainChek™ has excellent validity and reliability properties, compared to the standard Abbey Pain Scale. • The study to be published in Dementia and Geriatric Cognitive Disorders confirms previous clinical findings published in the Journal of Alzheimer’s Disease (JAD). Another study demonstrating the excellent clinical performance of PainChek™ has been accepted for publication in Dementia and Geriatric Cognitive Disorders, a prestigious and top tier peer reviewed journal devoted to the study of cognitive dysfunction in preclinical and clinical studies. The study which used a later version of App confirmed the positive findings (including excellent validity and reliability) previously published in the Journal of Alzheimer’s Disease (JAD) in August, 2017." Read more.....

13 December, 2017